Sign in

NCT06131853Completed

Kinesiophobia in Prostate Cancer

Physical Activity, Fear of Falling, Fatigue and Functionality in Prostate Cancer

Source: ClinicalTrials.gov · Last updated 29 Jan 2024

Brief summary (registry, in English)

This study aimed to investigate the effects of prostate cancer on patients' physical activity, kinesiophobia, fatigue and functionality. This research is a prospective study to be conducted on volunteer individuals between the ages of 40-75. People diagnosed with prostate cancer (study group) and healthy adults who have not been diagnosed with prostate cancer before (control group) will be included in the study. The demographic characteristics, physical activity levels and quality of life of all individuals participating in the study will be evaluated with an online form. In demographic data, physical, sociodemographic data such as age (years), height (cm), body weight (kg), body mass index (kg/m2) and disease-specific information will be recorded. Physical activity level will be measured with the International Physical Activity Survey short form (UFAA), fatigue with the Functional Evaluation of Chronic Disease Treatment-Fatigue Questionnaire, fear of movement with the Causes of Fear of Movement Questionnaire, and quality of life with the Functional Evaluation of Cancer Treatment-Prostate Version questionnaire (KHTFD-Y).

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
9 Nov 2023
Start date
9 Nov 2023
Primary completion date
20 Nov 2023
Lead sponsor
Selcuk University
NCT number
NCT06131853

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 9 Nov 2023 to the primary completion date, 20 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those with a previously known or accompanying diagnosis of dementia
  • Having undergone chemotherapy and radiotherapy in the last 6 months

Other illness

  • The individual has a disease that may prevent him or her from understanding and completing the survey.

Other

  • Not wanting to participate in the study
  • Illiterates
  • Those who do not want to participate in the research voluntarily
  • Having active metastasis

Who the study is looking for

  • (for prostate cancer-study group)
    • Being between the ages of 40-75
    • Want to participate in the study
    • Being able to read and write
    • Being diagnosed with prostate cancer by a specialist physician,
    • Being able to provide their mobility independently,
  • (for healthy controls - control group)
    • Being between the ages of 40-75
    • Not having any previous cancer history and not having undergone cancer surgery
    • Volunteering to participate in the study

Age in the registry: 40 years to 75 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Selçuk University
Coordinator of this site? Confirm its status
KonyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.